These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 28030632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 5. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
    Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ.
    Neuro Oncol; 2009 Dec 01; 11(6):737-46. PubMed ID: 19224764
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
    Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A.
    J Neuropathol Exp Neurol; 2004 Apr 01; 63(4):314-22. PubMed ID: 15099021
    [Abstract] [Full Text] [Related]

  • 7. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
    Ramirez C, Bowman C, Maurage CA, Dubois F, Blond S, Porchet N, Escande F.
    Neuro Oncol; 2010 May 01; 12(5):490-9. PubMed ID: 20156805
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.
    Clin Neuropathol; 2006 May 01; 25(1):18-24. PubMed ID: 16465770
    [Abstract] [Full Text] [Related]

  • 9. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
    Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB.
    J Clin Oncol; 2000 Feb 01; 18(3):636-45. PubMed ID: 10653879
    [Abstract] [Full Text] [Related]

  • 10. 1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.
    Andrews C, Prayson RA.
    Ann Diagn Pathol; 2020 Jun 01; 46():151519. PubMed ID: 32305004
    [Abstract] [Full Text] [Related]

  • 11. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
    Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.
    J Natl Cancer Inst; 1998 Oct 07; 90(19):1473-9. PubMed ID: 9776413
    [Abstract] [Full Text] [Related]

  • 12. Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.
    Godfraind C, Rousseau E, Ruchoux MM, Scaravilli F, Vikkula M.
    Neuropathol Appl Neurobiol; 2003 Oct 07; 29(5):462-71. PubMed ID: 14507338
    [Abstract] [Full Text] [Related]

  • 13. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
    Li YX, Shi Z, Aibaidula A, Chen H, Tang Q, Li KK, Chung NY, Chan DT, Poon WS, Mao Y, Wu J, Zhou L, Chan AK, Ng HK.
    Oncotarget; 2016 Oct 04; 7(40):64615-64630. PubMed ID: 27556304
    [Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.
    Thiessen B, Maguire JA, McNeil K, Huntsman D, Martin MA, Horsman D.
    J Neurooncol; 2003 Sep 04; 64(3):271-8. PubMed ID: 14558604
    [Abstract] [Full Text] [Related]

  • 15. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2002 Mar 04; 103(3):267-75. PubMed ID: 11907807
    [Abstract] [Full Text] [Related]

  • 16. Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors.
    Trost D, Ehrler M, Fimmers R, Felsberg J, Sabel MC, Kirsch L, Schramm J, Wiestler OD, Reifenberger G, Weber RG.
    Int J Cancer; 2007 Jun 01; 120(11):2368-76. PubMed ID: 17285580
    [Abstract] [Full Text] [Related]

  • 17. The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.
    Horbinski C, Nikiforova MN, Hobbs J, Bortoluzzi S, Cieply K, Dacic S, Hamilton RL.
    J Neuropathol Exp Neurol; 2012 Jan 01; 71(1):73-82. PubMed ID: 22157622
    [Abstract] [Full Text] [Related]

  • 18. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
    Singh VY, Chacko G, Chacko AG, Rajshekhar V.
    Neurol India; 2014 Jan 01; 62(1):32-6. PubMed ID: 24608451
    [Abstract] [Full Text] [Related]

  • 19. Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.
    Michaud K, de Tayrac M, D'Astous M, Paquet C, Gould PV, Saikali S.
    PLoS One; 2018 Jan 01; 13(2):e0193213. PubMed ID: 29489901
    [Abstract] [Full Text] [Related]

  • 20. Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.
    Habiba U, Sugino H, Yordanova R, Ise K, Tanei ZI, Ishida Y, Tanikawa S, Terasaka S, Sato KI, Kamoshima Y, Katoh M, Nagane M, Shibahara J, Tsuda M, Tanaka S.
    Acta Neuropathol Commun; 2021 May 21; 9(1):95. PubMed ID: 34020723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.